Reasons for non-recruitment of eligible patients to a randomised controlled trial of secondary prevention after intracerebral haemorrhage: observational study.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620340
Title:
Reasons for non-recruitment of eligible patients to a randomised controlled trial of secondary prevention after intracerebral haemorrhage: observational study.
Authors:
Maxwell, A. E.; MacLeod, M. J.; Joyson, A.; Johnson, S.; Ramadan, H.; Bellfield, R.; Byrne, A.; McGhee, C.; Rudd, A.; Price, F.; Vasileiadis, E.; Holden, M.; Hewitt, J.; Carpenter, M.; Needle, A.; Valentine, S.; Patel, F.; Harrington, F.; Mudd, Paul; Emsley, H.; Gregary, B.; Kane, I.; Muir, K.; Tiwari, D.; Owusu-Agyei, P.; Temple, N.; Sekaran, L.; Ragab, S.; England, T.; Hedstrom, A.; Jones, P.; Jones, S.; Doherty, M.; McCarron, M. O.; Cohen, D. L.; Tysoe, S.; Al-Shahi Salman, R.
Abstract:
Recruitment to randomised prevention trials is challenging, not least for intracerebral haemorrhage (ICH) associated with antithrombotic drug use. We investigated reasons for not recruiting apparently eligible patients at hospital sites that keep screening logs in the ongoing REstart or STop Antithrombotics Randomised Trial (RESTART), which seeks to determine whether to start antiplatelet drugs after ICH.
Citation:
Reasons for non-recruitment of eligible patients to a randomised controlled trial of secondary prevention after intracerebral haemorrhage: observational study. 2017, 18 (1):162 Trials
Publisher:
BioMed Central
Journal:
Trials
Issue Date:
5-Apr-2017
URI:
http://hdl.handle.net/11287/620340
DOI:
10.1186/s13063-017-1909-4
PubMed ID:
28381307
Additional Links:
https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-017-1909-4
Note:
EDGE project number 14013
Type:
Journal Article
Language:
en
ISSN:
1745-6215
Appears in Collections:
Stroke; 2017 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorMaxwell, A. E.en
dc.contributor.authorMacLeod, M. J.en
dc.contributor.authorJoyson, A.en
dc.contributor.authorJohnson, S.en
dc.contributor.authorRamadan, H.en
dc.contributor.authorBellfield, R.en
dc.contributor.authorByrne, A.en
dc.contributor.authorMcGhee, C.en
dc.contributor.authorRudd, A.en
dc.contributor.authorPrice, F.en
dc.contributor.authorVasileiadis, E.en
dc.contributor.authorHolden, M.en
dc.contributor.authorHewitt, J.en
dc.contributor.authorCarpenter, M.en
dc.contributor.authorNeedle, A.en
dc.contributor.authorValentine, S.en
dc.contributor.authorPatel, F.en
dc.contributor.authorHarrington, F.en
dc.contributor.authorMudd, Paulen
dc.contributor.authorEmsley, H.en
dc.contributor.authorGregary, B.en
dc.contributor.authorKane, I.en
dc.contributor.authorMuir, K.en
dc.contributor.authorTiwari, D.en
dc.contributor.authorOwusu-Agyei, P.en
dc.contributor.authorTemple, N.en
dc.contributor.authorSekaran, L.en
dc.contributor.authorRagab, S.en
dc.contributor.authorEngland, T.en
dc.contributor.authorHedstrom, A.en
dc.contributor.authorJones, P.en
dc.contributor.authorJones, S.en
dc.contributor.authorDoherty, M.en
dc.contributor.authorMcCarron, M. O.en
dc.contributor.authorCohen, D. L.en
dc.contributor.authorTysoe, S.en
dc.contributor.authorAl-Shahi Salman, R.en
dc.date.accessioned2017-05-25T12:39:05Z-
dc.date.available2017-05-25T12:39:05Z-
dc.date.issued2017-04-05-
dc.identifier.citationReasons for non-recruitment of eligible patients to a randomised controlled trial of secondary prevention after intracerebral haemorrhage: observational study. 2017, 18 (1):162 Trialsen
dc.identifier.issn1745-6215-
dc.identifier.pmid28381307-
dc.identifier.doi10.1186/s13063-017-1909-4-
dc.identifier.urihttp://hdl.handle.net/11287/620340-
dc.description.abstractRecruitment to randomised prevention trials is challenging, not least for intracerebral haemorrhage (ICH) associated with antithrombotic drug use. We investigated reasons for not recruiting apparently eligible patients at hospital sites that keep screening logs in the ongoing REstart or STop Antithrombotics Randomised Trial (RESTART), which seeks to determine whether to start antiplatelet drugs after ICH.en
dc.language.isoenen
dc.publisherBioMed Centralen
dc.relation.urlhttps://trialsjournal.biomedcentral.com/articles/10.1186/s13063-017-1909-4en
dc.rightsArchived with thanks to Trials. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en
dc.subjectWessex Classification Subject Headings::Neurology::Strokeen
dc.titleReasons for non-recruitment of eligible patients to a randomised controlled trial of secondary prevention after intracerebral haemorrhage: observational study.en
dc.typeJournal Articleen
dc.identifier.journalTrialsen
dc.description.noteEDGE project number 14013en
dc.description.fundingBritish Heart Foundation Special Project (SP/12/2/29422) & Project (PG/14/50/30891) fundingen
dc.type.versionPublisheden
All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.